mar 99 has been researched along with pentagastrin in 1 studies
| Studies (mar 99) | Trials (mar 99) | Recent Studies (post-2010) (mar 99) | Studies (pentagastrin) | Trials (pentagastrin) | Recent Studies (post-2010) (pentagastrin) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 3,639 | 207 | 51 |
| Protein | Taxonomy | mar 99 (IC50) | pentagastrin (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.8875 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizuka, Y; Kamisaki, T; Kamiya, A; Kataoka, M; Kawashima, M; Kimura, I; Matsuda, M; Okamoto, N; Shimazaki, I; Terashima, K | 1 |
1 other study(ies) available for mar 99 and pentagastrin
| Article | Year |
|---|---|
Effect of 1,6-dihydro-2-[2-(2-methylpropoxy)anilino]-6-oxo-5-pyrimidinecarboxylic acid on gastric mucosal defensive factors and gastric secretion in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Carbachol; Epithelial Cells; Epithelium; Ethanol; Gastric Acid; Gastric Mucosa; Hexosamines; Histamine; In Vitro Techniques; Indomethacin; Male; Membrane Potentials; Mucus; Pentagastrin; Pyrimidines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Stomach | 1994 |